US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 0.8379
  • +0.0077+0.93%
Close Feb 18 16:00 ET
  • 0.8379
  • 0.00000.00%
Post 16:02 ET
105.41MMarket Cap-3.99P/E (TTM)

About Atossa Therapeutics Company

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Company Profile

SymbolATOS
Company NameAtossa Therapeutics
Listing DateNov 8, 2012
Issue Price5.00
Founded2008
CEODr. Steven C. Quay, M.D.
MarketNASDAQ
Employees12
Fiscal Year Ends12-31
Address10202 5th Avenue North East,Suite 200
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98125
Phone1-206-588-0256
Websitehttp://www.atossatherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Steven C. Quay, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 2.36M
  • Heather Rees
  • Senior Vice President, Finance and Accounting and Principal Accounting Officer
  • 687.46K
  • Dr. Shu-Chih Chen, PhD
  • Director
  • 116.17K
  • Dr. Tessa Cigler, M.D.,M.P.H.
  • Director
  • --
  • Richard I. Steinhart
  • Independent Director
  • 146.17K
  • Dr. Stephen J. Galli, M.D.
  • Independent Director
  • 144.92K
  • Jonathan F. Finn, C.F.A.
  • Independent Director
  • 93.98K
  • H. Lawrence Remmel
  • Independent Director
  • 144.92K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.